about
A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeuticsPulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives.Epithelial to Mesenchymal Transition (EMT) and Endothelial to Mesenchymal Transition (EndMT): Role and Implications in Kidney Fibrosis.Risk Stratification of Patients With Current Generation Continuous-Flow Left Ventricular Assist Devices Being Bridged to Heart Transplantation.Anemia after continuous-flow left ventricular assist device implantation: characteristics and implications.Melding a High-Risk Patient for Continuous Flow Left Ventricular Assist Device into a Low-Risk Patient.Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension.Measles and respiratory failure: Case report and review of the last European outbreaks
P50
Q30802055-3DF54509-D54E-4594-BC50-5921946561E6Q37668859-4B373984-A710-4E73-A228-4DD3C8EB6E07Q39242491-ECE89193-E6CB-4DDF-8616-C4B6B54D572BQ47699628-A8F91F61-1FA7-45CC-9FAF-CCFD79692AE8Q48010697-C073D6B1-BA85-495F-902B-1538322C4AB6Q50875105-4DC6DF6C-16C1-4870-A48A-C5C92EA0ED9DQ52885411-563E4396-BBBF-4412-ACE0-075C25C871B2Q57237685-2B1525ED-004E-4266-99DE-A4A790CC897B
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ana S Cruz-Solbes
@ast
Ana S Cruz-Solbes
@en
Ana S Cruz-Solbes
@es
Ana S Cruz-Solbes
@nl
Ana S Cruz-Solbes
@sl
type
label
Ana S Cruz-Solbes
@ast
Ana S Cruz-Solbes
@en
Ana S Cruz-Solbes
@es
Ana S Cruz-Solbes
@nl
Ana S Cruz-Solbes
@sl
prefLabel
Ana S Cruz-Solbes
@ast
Ana S Cruz-Solbes
@en
Ana S Cruz-Solbes
@es
Ana S Cruz-Solbes
@nl
Ana S Cruz-Solbes
@sl
P106
P1153
56737047000
P21
P31
P496
0000-0003-1438-9283